Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Current Assets: 2020-2024

Historic Current Assets for Cellebrite DI (CLBT) over the last 5 years, with Dec 2024 value amounting to $567.6 million.

  • Cellebrite DI's Current Assets rose 33.29% to $668.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $668.4 million, marking a year-over-year increase of 33.29%. This contributed to the annual value of $567.6 million for FY2024, which is 34.47% up from last year.
  • As of FY2024, Cellebrite DI's Current Assets stood at $567.6 million, which was up 34.47% from $422.1 million recorded in FY2023.
  • In the past 5 years, Cellebrite DI's Current Assets registered a high of $567.6 million during FY2024, and its lowest value of $273.2 million during FY2021.
  • For the 3-year period, Cellebrite DI's Current Assets averaged around $428.5 million, with its median value being $422.1 million (2023).
  • Its Current Assets has fluctuated over the past 5 years, first dropped by 15.75% in 2021, then soared by 42.63% in 2023.
  • Yearly analysis of 5 years shows Cellebrite DI's Current Assets stood at $324.3 million in 2020, then dropped by 15.75% to $273.2 million in 2021, then increased by 8.32% to $295.9 million in 2022, then surged by 42.63% to $422.1 million in 2023, then surged by 34.47% to $567.6 million in 2024.